ACI - 4th Annual Paragraph IV Disputes Conference
Event | 04.27.10 - 04.28.10, 12:00 AM UTC - 12:00 AM UTC
Now in its fourth year, ACI’s Paragraph IV Disputes conference has become the most trusted source for the ‘ins and outs’ of Paragraph IV litigation. This first and original conference of its kind serves as the litigation playbook for brand name and generic drug companies in the high-stakes arena of Hatch-Waxman litigation.
Teresa Rea is one of the speakers addressing "New Takes on Obviousness: Pre-Suit Considerations for Brand-Names and Generics".
Insights
Event | 12.04.25
ACI 30th Annual Conference on Drug & Medical Device Litigation
Dan Campbell with Speak on the panel "Mastering MDL Case Management: What Proposed Rule 16.1 Really Means for Consolidated Litigation."
Rule 16.1 attempts to guide early case management in MDLs, impacting litigation pace and costs. Permissive language like “should” instead of “must”, could lead to inconsistent applications. This panel will explore the rule’s anticipated impact and implications for procedures.
Event | 12.03.25 - 12.04.25
Caroline Brown to Speak at ACI New York Forum on Economic Sanctions
Event | 11.04.25
